Sanfu Biomedical Partners with Up Therapeutics to Develop New Cancer Drugs
At the recent Asia Biotech Exhibition, Sanfu Biomedical announced a licensing agreement with the U.S.-based Up Therapeutics to jointly develop a new type of cancer drug. This collaboration will leverage both parties' expertise and resources to accelerate research in cancer treatment.
Sanfu Biomedical emphasized that this partnership is expected to significantly enhance the efficiency of cancer drug development and could offer new treatment options for cancer patients globally. The company also stated that it will continue to explore collaboration opportunities with international partners to promote growth in the biotech industry.
